SULPHINPYRAZONE METABOLISM DURING LONG-TERM THERAPY

被引:26
作者
PEDERSEN, AK
JAKOBSEN, P
机构
关键词
D O I
10.1111/j.1365-2125.1981.tb01176.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:597 / 603
页数:7
相关论文
共 20 条
[1]   DISPOSITION AND OXIDATIVE-METABOLISM OF PHENYLBUTAZONE IN MAN [J].
AARBAKKE, J ;
BAKKE, OM ;
MILDE, EJ ;
DAVIES, DS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (05) :359-366
[2]  
ALI M, 1977, J LAB CLIN MED, V89, P868
[3]   TREATMENT OF THE PATIENT AFTER MYOCARDIAL-INFARCTION - LAST DECADE AND THE NEXT [J].
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (05) :290-293
[4]  
BRODIE BB, 1954, P SOC EXP BIOL MED, V86, P884
[5]   PROLONGED EFFECT OF SULFINPYRAZONE ON COLLAGEN-INDUCED PLATELET-AGGREGATION INVIVO [J].
BUCHANAN, MR ;
ROSENFELD, J ;
HIRSH, J .
THROMBOSIS RESEARCH, 1978, 13 (05) :883-892
[6]  
BURNS JJ, 1957, J PHARMACOL EXP THER, V119, P418
[7]  
BUTLER K D, 1979, Thrombosis and Haemostasis, V42, P101
[8]  
DAYTON PG, 1961, J PHARMACOL EXP THER, V132, P287
[9]   BIOTRANSFORMATION AND PHARMACOKINETICS OF SULFINPYRAZONE (ANTURAN) IN MAN [J].
DIETERLE, W ;
FAIGLE, JW ;
MORY, H ;
RICHTER, WJ ;
THEOBALD, W .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :135-145
[10]  
HUCKER HB, 1973, DRUG METAB DISPOS, V1, P721